Skip to main navigation Skip to search Skip to main content

Treating lymphoma or leukemia in a patient comprises modulating the level of an expression product of a gene selected from PI3KR1, GNAS, NESP5, JAK1, neurogranin, HIPK1, or Nrf2

  • Finn Skou Pedersen (Inventor)
  • , Annette Balle Sørensen (Inventor)
  • , Anne Ahlmann Nielsen (Inventor)
  • , Javier Martin Hernandez (Inventor)
  • , Helle Moving (Inventor)
  • Aarhus University

Research output: Patent

Original languageEnglish
IPCA61K-039/395
Patent numberUS2007098728-A1
Filing date03/05/2007
Country/TerritoryUnited States
Publication statusPublished - 2007
Externally publishedYes

Cite this